|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 901 to 1000 out of 2547 for Pten

Category restricted to Publication (x)

0.021s

Categories

Category: Publication
Type Details Score
Publication
First Author: Eroglu B
Year: 2020
Journal: Mol Cancer Res
Title: HSF1-Mediated Control of Cellular Energy Metabolism and mTORC1 Activation Drive Acute T-Cell Lymphoblastic Leukemia Progression.
Volume: 18
Issue: 3
Pages: 463-476
Publication
First Author: Kenerson HL
Year: 2011
Journal: PLoS One
Title: Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation.
Volume: 6
Issue: 3
Pages: e18075
Publication
First Author: Zhang B
Year: 2014
Journal: Oncogene
Title: A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis.
Volume: 33
Issue: 24
Pages: 3099-108
Publication
First Author: Sun ZJ
Year: 2013
Journal: PLoS One
Title: Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model.
Volume: 8
Issue: 10
Pages: e74888
Publication
First Author: Tien JC
Year: 2013
Journal: Cancer Res
Title: The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.
Volume: 73
Issue: 13
Pages: 3997-4008
Publication
First Author: Qin J
Year: 2014
Journal: J Clin Invest
Title: Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.
Volume: 124
Issue: 11
Pages: 5013-26
Publication
First Author: Chen Z
Year: 2005
Journal: Nature
Title: Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
Volume: 436
Issue: 7051
Pages: 725-30
Publication
First Author: Nardella C
Year: 2009
Journal: Sci Signal
Title: Differential requirement of mTOR in postmitotic tissues and tumorigenesis.
Volume: 2
Issue: 55
Pages: ra2
Publication
First Author: Li F
Year: 2020
Journal: J Clin Invest
Title: ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming.
Volume: 130
Issue: 11
Pages: 5924-5941
Publication
First Author: Antico Arciuch VG
Year: 2013
Journal: Cancer Res
Title: Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cells.
Volume: 73
Issue: 17
Pages: 5459-72
Publication
First Author: Wan L
Year: 2017
Journal: Cancer Discov
Title: The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
Volume: 7
Issue: 4
Pages: 424-441
Publication
First Author: Alcantara Llaguno S
Year: 2019
Journal: Nat Neurosci
Title: Cell-of-origin susceptibility to glioblastoma formation declines with neural lineage restriction.
Volume: 22
Issue: 4
Pages: 545-555
Publication    
First Author: Chua CW
Year: 2018
Journal: Elife
Title: Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation.
Volume: 7
Publication      
First Author: Liu J
Year: 2015
Journal: Cell Rep
Title: ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis.
Publication
First Author: Cartoni R
Year: 2016
Journal: Neuron
Title: The Mammalian-Specific Protein Armcx1 Regulates Mitochondrial Transport during Axon Regeneration.
Volume: 92
Issue: 6
Pages: 1294-1307
Publication
First Author: Snaidero N
Year: 2014
Journal: Cell
Title: Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue.
Volume: 156
Issue: 1-2
Pages: 277-90
Publication
First Author: Portale F
Year: 2024
Journal: Nat Commun
Title: C/EBPβ-dependent autophagy inhibition hinders NK cell function in cancer.
Volume: 15
Issue: 1
Pages: 10343
Publication
First Author: Lukacs RU
Year: 2010
Journal: Cell Stem Cell
Title: Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation.
Volume: 7
Issue: 6
Pages: 682-93
Publication
First Author: Qi Z
Year: 2022
Journal: Nat Commun
Title: Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment.
Volume: 13
Issue: 1
Pages: 182
Publication
First Author: Lee J
Year: 2020
Journal: Nature
Title: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.
Volume: 588
Issue: 7838
Pages: 491-497
Publication
First Author: Liao K
Year: 2024
Journal: Cell Rep
Title: Critical roles of the miR-17∼92 family in thymocyte development, leukemogenesis, and autoimmunity.
Volume: 43
Issue: 6
Pages: 114261
Publication
First Author: Pan Y
Year: 2018
Journal: PLoS One
Title: Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.
Volume: 13
Issue: 5
Pages: e0190001
Publication
First Author: Chen L
Year: 2010
Journal: Nature
Title: CD95 promotes tumour growth.
Volume: 465
Issue: 7297
Pages: 492-6
Publication
First Author: Boyer A
Year: 2009
Journal: Carcinogenesis
Title: Dysregulation of WNT/CTNNB1 and PI3K/AKT signaling in testicular stromal cells causes granulosa cell tumor of the testis.
Volume: 30
Issue: 5
Pages: 869-78
Publication
First Author: Liu X
Year: 2017
Journal: Nat Cell Biol
Title: Regulation of mitochondrial biogenesis in erythropoiesis by mTORC1-mediated protein translation.
Volume: 19
Issue: 6
Pages: 626-638
Publication
First Author: Owczarek TB
Year: 2017
Journal: Cancer Res
Title: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.
Volume: 77
Issue: 4
Pages: 1035-1046
Publication
First Author: Jacquelot N
Year: 2021
Journal: Nat Immunol
Title: Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Volume: 22
Issue: 7
Pages: 851-864
Publication
First Author: Vanden Borre P
Year: 2014
Journal: Thyroid
Title: The next generation of orthotopic thyroid cancer models: immunocompetent orthotopic mouse models of BRAF V600E-positive papillary and anaplastic thyroid carcinoma.
Volume: 24
Issue: 4
Pages: 705-14
Publication
First Author: Maniati E
Year: 2020
Journal: Cell Rep
Title: Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment.
Volume: 30
Issue: 2
Pages: 525-540.e7
Publication
First Author: Mollaoglu G
Year: 2017
Journal: Cancer Cell
Title: MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
Volume: 31
Issue: 2
Pages: 270-285
Publication
First Author: Hamza B
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer.
Volume: 116
Issue: 6
Pages: 2232-2236
Publication
First Author: Kenchappa RS
Year: 2020
Journal: iScience
Title: Myosin 10 Regulates Invasion, Mitosis, and Metabolic Signaling in Glioblastoma.
Volume: 23
Issue: 12
Pages: 101802
Publication
First Author: Kenchappa RS
Year: 2021
Journal: Cell Rep
Title: Protein kinase C(ι) and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities.
Volume: 37
Issue: 8
Pages: 110054
Publication
First Author: Omori SA
Year: 2006
Journal: Immunity
Title: Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling.
Volume: 25
Issue: 4
Pages: 545-57
Publication
First Author: Cheung G
Year: 2024
Journal: Neuron
Title: Multipotent progenitors instruct ontogeny of the superior colliculus.
Volume: 112
Issue: 2
Pages: 230-246.e11
Publication
First Author: Zeng H
Year: 2016
Journal: Immunity
Title: mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation.
Volume: 45
Issue: 3
Pages: 540-554
Publication  
First Author: Bonet C
Year: 2017
Journal: J Natl Cancer Inst
Title: Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
Volume: 109
Issue: 8
Publication
First Author: Picariello HS
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner.
Volume: 116
Issue: 31
Pages: 15550-15559
Publication
First Author: Jarjour AA
Year: 2015
Journal: PLoS Biol
Title: The polarity protein Scribble regulates myelination and remyelination in the central nervous system.
Volume: 13
Issue: 3
Pages: e1002107
Publication
First Author: Belin S
Year: 2015
Journal: Neuron
Title: Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics.
Volume: 86
Issue: 4
Pages: 1000-1014
Publication
First Author: Li S
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Promoting axon regeneration in the adult CNS by modulation of the melanopsin/GPCR signaling.
Volume: 113
Issue: 7
Pages: 1937-42
Publication
First Author: Kim O
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Targeting progesterone signaling prevents metastatic ovarian cancer.
Volume: 117
Issue: 50
Pages: 31993-32004
Publication
First Author: Yu C
Year: 2015
Journal: Mol Hum Reprod
Title: CRL4DCAF1 is required in activated oocytes for follicle maintenance and ovulation.
Volume: 21
Issue: 2
Pages: 195-205
Publication
First Author: Kinross KM
Year: 2015
Journal: FASEB J
Title: Ubiquitous expression of the Pik3caH1047R mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly.
Volume: 29
Issue: 4
Pages: 1426-34
Publication
First Author: Moynihan KD
Year: 2016
Journal: Nat Med
Title: Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses.
Volume: 22
Issue: 12
Pages: 1402-1410
Publication
First Author: Ruiz R
Year: 2017
Journal: PLoS Genet
Title: The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas.
Volume: 13
Issue: 7
Pages: e1006913
Publication
First Author: Zhu HH
Year: 2011
Journal: Blood
Title: Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.
Volume: 117
Issue: 20
Pages: 5350-61
Publication
First Author: Kim J
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: High-grade serous ovarian cancer arises from fallopian tube in a mouse model.
Volume: 109
Issue: 10
Pages: 3921-6
Publication
First Author: Yeung TL
Year: 2019
Journal: J Natl Cancer Inst
Title: Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
Volume: 111
Issue: 3
Pages: 272-282
Publication
First Author: Tshering LF
Year: 2023
Journal: Dev Cell
Title: Immune mechanisms shape the clonal landscape during early progression of prostate cancer.
Volume: 58
Issue: 12
Pages: 1071-1086.e8
Publication
First Author: Kun EHS
Year: 2020
Journal: Sci Rep
Title: Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations.
Volume: 10
Issue: 1
Pages: 20678
Publication  
First Author: Ren Y
Year: 2015
Journal: BMC Biol
Title: Lhx8 regulates primordial follicle activation and postnatal folliculogenesis.
Volume: 13
Pages: 39
Publication
First Author: Getahun A
Year: 2016
Journal: J Exp Med
Title: Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells.
Volume: 213
Issue: 5
Pages: 751-69
Publication
First Author: Rivadeneira DB
Year: 2019
Journal: Immunity
Title: Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance.
Volume: 51
Issue: 3
Pages: 548-560.e4
Publication  
First Author: Patel R
Year: 2018
Journal: EMBO Mol Med
Title: Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.
Volume: 10
Issue: 4
Publication
First Author: Lei L
Year: 2011
Journal: PLoS One
Title: Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype.
Volume: 6
Issue: 5
Pages: e20041
Publication
First Author: Vengoji R
Year: 2021
Journal: J Exp Clin Cancer Res
Title: Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma.
Volume: 40
Issue: 1
Pages: 335
Publication
First Author: Paine MR
Year: 2016
Journal: PLoS One
Title: Whole Reproductive System Non-Negative Matrix Factorization Mass Spectrometry Imaging of an Early-Stage Ovarian Cancer Mouse Model.
Volume: 11
Issue: 5
Pages: e0154837
Publication
First Author: Xie XP
Year: 2022
Journal: Dev Cell
Title: Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy.
Volume: 57
Issue: 1
Pages: 32-46.e8
Publication  
First Author: Han X
Year: 2023
Journal: J Clin Invest
Title: Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models.
Volume: 133
Issue: 6
Publication
First Author: Jacobi A
Year: 2022
Journal: Neuron
Title: Overlapping transcriptional programs promote survival and axonal regeneration of injured retinal ganglion cells.
Volume: 110
Issue: 16
Pages: 2625-2645.e7
Publication
First Author: Ferretti R
Year: 2016
Journal: Genes Dev
Title: BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.
Volume: 30
Issue: 1
Pages: 18-33
Publication
First Author: Wang J
Year: 2020
Journal: Neuron
Title: Robust Myelination of Regenerated Axons Induced by Combined Manipulations of GPR17 and Microglia.
Volume: 108
Issue: 5
Pages: 876-886.e4
Publication
First Author: Franciosi F
Year: 2016
Journal: Endocrinology
Title: FSH Regulates mRNA Translation in Mouse Oocytes and Promotes Developmental Competence.
Volume: 157
Issue: 2
Pages: 872-82
Publication
First Author: Xie Q
Year: 2017
Journal: J Biol Chem
Title: Transcriptional regulation of the Nkx3.1 gene in prostate luminal stem cell specification and cancer initiation via its 3' genomic region.
Volume: 292
Issue: 33
Pages: 13521-13530
Publication
First Author: Antico-Arciuch VG
Year: 2010
Journal: Oncogene
Title: Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females.
Volume: 29
Issue: 42
Pages: 5678-86
Publication
First Author: Sun ZJ
Year: 2012
Journal: Clin Cancer Res
Title: Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.
Volume: 18
Issue: 19
Pages: 5304-13
Publication
First Author: Zhu H
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis.
Volume: 106
Issue: 8
Pages: 2712-6
Publication
First Author: Xie Y
Year: 2016
Journal: Oncotarget
Title: MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo.
Volume: 7
Issue: 30
Pages: 47609-47619
Publication
First Author: Chen Z
Year: 2009
Journal: Sci Signal
Title: Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Volume: 2
Issue: 84
Pages: ra44
Publication
First Author: Alimonti A
Year: 2010
Journal: J Clin Invest
Title: A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.
Volume: 120
Issue: 3
Pages: 681-93
Publication
First Author: Zhang Q
Year: 2014
Journal: Prostate
Title: Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment.
Volume: 74
Issue: 8
Pages: 869-79
Publication
First Author: Adhikari D
Year: 2010
Journal: Hum Mol Genet
Title: Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles.
Volume: 19
Issue: 3
Pages: 397-410
Publication
First Author: Ding M
Year: 2018
Journal: Mol Cancer Res
Title: The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Volume: 16
Issue: 4
Pages: 682-695
Publication
First Author: González-Billalabeitia E
Year: 2014
Journal: Cancer Discov
Title: Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.
Volume: 4
Issue: 8
Pages: 896-904
Publication
First Author: Zhao GF
Year: 2017
Journal: Oncotarget
Title: Cytokeratin 19 promoter directs the expression of Cre recombinase in various epithelia of transgenic mice.
Volume: 8
Issue: 11
Pages: 18303-18311
Publication
First Author: Dorr C
Year: 2015
Journal: Mol Cancer Res
Title: Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor.
Volume: 13
Issue: 8
Pages: 1238-47
Publication
First Author: Jiao J
Year: 2014
Journal: J Immunol
Title: Central role of conventional dendritic cells in regulation of bone marrow release and survival of neutrophils.
Volume: 192
Issue: 7
Pages: 3374-82
Publication
First Author: Gao Y
Year: 2017
Journal: J Pathol
Title: Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
Volume: 243
Issue: 1
Pages: 89-99
Publication
First Author: Deuker MM
Year: 2015
Journal: Cancer Discov
Title: PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma.
Volume: 5
Issue: 2
Pages: 143-53
Publication
First Author: Moon BC
Year: 2012
Journal: Arterioscler Thromb Vasc Biol
Title: Apolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling.
Volume: 32
Issue: 2
Pages: 236-46
Publication
First Author: Hernando E
Year: 2007
Journal: Nat Med
Title: The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.
Volume: 13
Issue: 6
Pages: 748-53
Publication
First Author: Moose DL
Year: 2020
Journal: Cell Rep
Title: Cancer Cells Resist Mechanical Destruction in Circulation via RhoA/Actomyosin-Dependent Mechano-Adaptation.
Volume: 30
Issue: 11
Pages: 3864-3874.e6
Publication
First Author: Sharma S
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Volume: 117
Issue: 14
Pages: 8001-8012
Publication
First Author: Zuchero JB
Year: 2015
Journal: Dev Cell
Title: CNS myelin wrapping is driven by actin disassembly.
Volume: 34
Issue: 2
Pages: 152-67
Publication
First Author: Caviglia JM
Year: 2018
Journal: Hepatology
Title: MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis.
Volume: 67
Issue: 6
Pages: 2414-2429
Publication
First Author: Dominguez D
Year: 2017
Journal: J Immunol
Title: Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.
Volume: 198
Issue: 3
Pages: 1365-1375
Publication
First Author: Grinberg-Bleyer Y
Year: 2017
Journal: Cell
Title: NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer.
Volume: 170
Issue: 6
Pages: 1096-1108.e13
Publication    
First Author: Patzig J
Year: 2016
Journal: Elife
Title: Septin/anillin filaments scaffold central nervous system myelin to accelerate nerve conduction.
Volume: 5
Publication
First Author: Ahmad I
Year: 2011
Journal: Dis Model Mech
Title: K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder.
Volume: 4
Issue: 4
Pages: 548-55
Publication
First Author: Kim J
Year: 2015
Journal: Endocrinology
Title: The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice.
Volume: 156
Issue: 6
Pages: 1975-81
Publication
First Author: Sun X
Year: 2009
Journal: Endocrinology
Title: In pursuit of leucine-rich repeat-containing G protein-coupled receptor-5 regulation and function in the uterus.
Volume: 150
Issue: 11
Pages: 5065-73
Publication
First Author: Joshi S
Year: 2014
Journal: Mol Cancer Res
Title: A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Volume: 12
Issue: 10
Pages: 1520-31
Publication
First Author: Soleder S
Year: 2024
Journal: Sci Rep
Title: Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation.
Volume: 14
Issue: 1
Pages: 25619
Publication
First Author: Hiroto A
Year: 2022
Journal: Nat Commun
Title: Stromal androgen signaling acts as tumor niches to drive prostatic basal epithelial progenitor-initiated oncogenesis.
Volume: 13
Issue: 1
Pages: 6552
Publication
First Author: Alcantara Llaguno S
Year: 2009
Journal: Cancer Cell
Title: Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.
Volume: 15
Issue: 1
Pages: 45-56
Publication
First Author: Wang LL
Year: 2016
Journal: Cell Rep
Title: The p53 Pathway Controls SOX2-Mediated Reprogramming in the Adult Mouse Spinal Cord.
Volume: 17
Issue: 3
Pages: 891-903
Publication
First Author: Wu N
Year: 2016
Journal: Oncotarget
Title: NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
Volume: 7
Issue: 36
Pages: 57514-57524
Publication
First Author: Hadji A
Year: 2014
Journal: Cell Rep
Title: Death induced by CD95 or CD95 ligand elimination.
Volume: 7
Issue: 1
Pages: 208-22
Publication
First Author: Mullany LK
Year: 2014
Journal: Mol Endocrinol
Title: Tumor repressor protein 53 and steroid hormones provide a new paradigm for ovarian cancer metastases.
Volume: 28
Issue: 1
Pages: 127-37